Gold-standard testing of individuals without COVID-19 symptoms key to controlling the spread WALTHAM, Mass. –(BUSINESS WIRE)–Jan. 14, 2021– PerkinElmer, Inc. (NYSE:PKI) announced today that its PerkinElmer ® New Coronavirus Nucleic Acid Detection Kit received Emergency Use Authorization (EUA)
